Everand Logo

Welcome to Everand!

  • NPR

    Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests

    In a preliminary study, the cancer drug nilotinib seemed to help patients with Parkinson's and dementia. Now two larger and more rigorous studies of the drug are under way.
    by Jon Hamilton Mar 15, 2017 3 minutes
    A colored magnetic resonance imaging (MRI) scans of the brain of a 76-year-old patient with dementia shows the brain has atrophied and the dark brown fluid-filled spaces have become enlarged.

    Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's.

    The drug is nilotinib, which is approved to treat a form of leukemia.

    In late 2015, researchers at Georgetown University Medical Center that small doses of the drug appeared to help a handful of people with Parkinson's disease and a related form of dementia. They'd tried the unlikely treatment because they knew nilotinib triggered cells to get

    You’re reading a preview, subscribe to read more.

    More from NPR

    NPR5 min read
    Can You Survive Summer Indoors Without AC? In Arizona, Many Don’t
    Nearly half of the people who suffered heat-related deaths in Arizona last year lived outdoors without shelter, but public health officials and lawmakers are starting to pay more attention to the risk of dying indoors.
    NPR4 min read
    'Hacks' Season 3 Is Proof That Compelling Storylines And Character Growth Take Time
    Ava (Hannah Einbinder) and Deborah (Jean Smart) have both grown a lot since we first met them in Season 1. It's a reminder that shows need breathing room to achieve satisfying development.
    NPR4 min read
    'Dance Your Ph.D.' Winner On Science, Art, And Embracing His Identity
    Weliton Menário Costa's award-winning music video showcases his research on kangaroo personality and behavior — and offers a celebration of human diversity, too.

    Related Books & Audiobooks